Scorpio feels strong today; your focus helps solve a hidden problem, you learn quickly, and close friends offer real support when you ask and grow. Scorpio Horoscope Today: Read our expert ...

One of India’s bestselling SUVs – the Mahindra Scorpio N – is finally set to get its long-awaited mid-cycle update in the second half of 2026, months after its sibling – the Mahindra XUV700 – receives ...

The upcoming Mahindra Scorpio N facelift is expected to receive minor design tweaks and upgraded features, while continuing with the existing powertrain options. Here is a quick look at the top three ...

Mahindra is preparing midlife updates for its popular SUVs, the XUV700 and Scorpio N, in 2026. The refreshed XUV700 is expected to launch in the first quarter, while the facelifted Scorpio N may ...

Scorpio, this week brings transformation and growth, starting with financial challenges that foster self-awareness. Midweek, your charisma shines, attracting success in deals and social events. The ...

Scorpio's focus sharpens today, revealing important feelings and practical paths. Trust instincts for small decisions, connect honestly, and channel energy into constructive, steady efforts ...

Good day, and a warm welcome to today's conference call of the PATRIZIA SE, following the publication of the 9-month financial results of 2025. [Operator Instructions] Having said this, I hand over to ...

Of all the signs in the zodiac, there are few more maligned or misunderstood than Scopio. The most powerful sign in the zodiac, Scorpio loves hard and holds on tight. They won’t settle for less than ...

Investment activities show further signs of improvement: closed acquisitions up by 41.0% evidencing investors returning to real assets, total closed transactions grew by 7.7% y-o-y PATRIZIA increases ...

Messenger planet Mercury enters the dark heart of Scorpio on Monday, October 6, where it will toil and boil before moving into Sagittarius on October 29th. Mercury rules communication of all kinds, ...

After leaving the FDA, where she served as director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., is returning to her previous employer: Big Pharma Pfizer. After leaving ...